edutradinguru

BFYT ( BENEFYTT )- STOCK PICKING #2

Long
NASDAQ:BFYT   None
Hello, here another great pick in the stock market (in the link attached you can find the #1, they are not presented in order of preferences). It is Benefytt, a telemedicine broker company that provides low cost insurance and organizes doctor and nurses visits at home. The aging population and the quarantene will probably help redirect the eyes of people towards the telemedicine sector.

Ehealth, a competitor, made a great run in 2018 without any covid-19 around, and the sector (ex-benefytt) quotes at 7x the multiple EV/sales.
Benefytt quotes at 2x, and we are in 2020 with corona spreading out, meaning that wecan see a similar run by the end of the year that can start anytime soon. They suffered in 2019 because of 3 acquisitions they made to eat competition, but they are DEEPLY undervalued in my opinion.

Forget about technicals now (even if there is a positive divergence in the RSI): we are around a local minimum, and the stock is not affected by general market condition. If it is, with virus going everywhere, it will be in a positive way.
The fall of few days ago was caused by general panic, nothing to do with the company itself. As for the dividends idea, market sometimes takes a while to figure out things, especially in these two weeks where everything happened so fast. It needs to reassess, and when it will, BFYT could go to 60 at least. I have been conservative on mutliple comparison, actually in thebest scenario in could do 4x, but we will keep this target as secondary one. Let's go to 60 first, then we I'll see how to adjust.

Here is what I will do:
Buy C 40 Jan 2021 @ 300usd

If T1 is reached : 6.7x (2,000 usd vs 300usd paid for each option)
If T2 is reached it wil be more than 10x with a single, but clever trade.


Are you a good trader but you lack the capital?
Or simply you don't want to risk it?

Trade forex, oil, crypto, indices, and keep 80% of the profits you make, while losses are covered!
Check it out now → ftmo.com/en/?affiliates=2427
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.